Alcohol and infectious diseases
The Global Diversion of Pharmaceutical Drugs series
Dilemmas in harm minimization
SUPPLY REDUCTION'S HIDDEN CASUALTIES
HARM REDUCTION IS A GOOD LABEL FOR A CRITERION ALL DRUG PROGRAMS SHOULD MEET
HARM REDUCTION—AN ETHICAL IMPERATIVE
HARM REDUCTION IS NOW THE MAINSTREAM GLOBAL DRUG POLICY
DILEMMAS IN HARM MINIMIZATION
The global diversion of pharmaceutical drugs
Homicide in Chicago from 1890 to 1930
A systematic review of work-place interventions for alcohol-related problems
Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use
[Commentary] MOVING ON TO COMORBIDITY, NEW MODES OF DELIVERY AND ACCEPTABILITY
Facilitating involvement in Alcoholics Anonymous during out-patient treatment
School-based alcohol education
Mortality risk up to 25 years after initiation of treatment among 420 Swedish women with alcohol addiction
Modeling the genetic and environmental association between peer group deviance and cannabis use in male twins
Pathways to cannabis abuse
[Commentary] GENETICALLY INFORMATIVE STUDIES OF ‘ENVIRONMENT’
Impact of US and Canadian precursor regulation on methamphetamine purity in the United States
HOW TO EXPAND THE ‘SAMPLE SIZE’ OF STUDIES OF DRUG MARKET DISRUPTIONS
THE HOLY GRAIL OF SUPPLY CONTROL
Methadone and impairment in apprehended drivers
Changes and predictors of change in the physical health status of heroin users over 24 months
Further evidence for an association between the gamma-aminobutyric acid receptor A, subunit 4 genes on chromosome 4 and Fagerström Test for Nicotine Dependence
Determinants of continuity and change over 10 years in young women's smoking
Prevalence and correlates of purchasing contraband cigarettes on First Nations reserves in Ontario, Canada
Changes in environmental tobacco smoke (ETS) exposure over a 20-year period
News and Notes